Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12612000449831Phase 4Completed
Phase 4, open-label, single-arm trial of insulin aspart in diabetes mellitus type 1 (T1D), sponsored by St Vincent's Hospital Melbourne. Primary endpoint: Time to reach steady state circulating insulin levels following a change in basal insulin infusion rate. Started Apr 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12612000449831.